Markets:

Overview

News

Currencies

International

Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

110.17 +1.43 (+1.32%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

19 20 Next >

Bull of the Day - NeoGenomics ↗

January 12, 2024

But in late December, shares took a big hit on patent litigation with competitor Natera. Let's review the primary commercial business of NEO and then that will help put the legal news into context.

Via Talk Markets

Topics Intellectual Property

7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024 ↗

January 08, 2024

Small cap stocks are anticipated to rise by as much as 50% in 2024 as investors look for growth in new areas of the market.

Via InvestorPlace

Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results

January 08, 2024

From Guardant Health, Inc.

Via Business Wire

4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024 ↗

January 08, 2024

Even if Wall Street is wrong about these stocks in the new year, Cathie Wood could still be right about them over the long run.

Via The Motley Fool

Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa

January 08, 2024

From Guardant Health, Inc.

Via Business Wire

What 7 Analyst Ratings Have To Say About Guardant Health ↗

December 13, 2023

Via Benzinga

Guardant Health Appoints Terilyn Juarez Monroe as Chief People Officer

January 02, 2024

From Guardant Health, Inc.

Via Business Wire

Guardant Health Announces $90.7 Million Registered Direct Offering with Baillie Gifford

December 21, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

December 20, 2023

From Guardant Health, Inc.

Via Business Wire

Blood-Based Colorectal Cancer CRC Screening Market Likely to Benefit From FDA's Panel Surprise Advisory Possibility: Analyst ↗

December 20, 2023

Tuesday, Guardant Health Inc (NASDAQ: GH) announced that the FDA's Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee is tentatively scheduled to review the premarket...

Via Benzinga

7 Analysts Have This to Say About Guardant Health ↗

November 13, 2023

Via Benzinga

Earnings Scheduled For November 6, 2023 ↗

November 06, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.

Via Benzinga

The Latest Analyst Ratings for Guardant Health ↗

October 20, 2023

Via Benzinga

S&P 500, Nasdaq Set For Weaker Open As 'FOMO' Rally Cools: Analyst Says Only 'Black Swan Could Upset Santa's Sleigh' Now ↗

December 20, 2023

Bond yields remain contained, providing a reason for traders to maintain their investments in stocks.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 19, 2023

Via Benzinga

Guardant Health Announces Tentative Date of FDA Advisory Panel Review of Shield™ Blood Test

December 19, 2023

From Guardant Health, Inc.

Via Business Wire

Cancer Research UK and Guardant Health Launch Collaboration to Advance Cancer Research and Clinical Development Activities

December 04, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and residual disease detection

November 30, 2023

From Guardant Health, Inc.

Via Business Wire

Jim Cramer: Buy This Financial Stock, 'It's Up Substantially From Where It Was In The Spring' ↗

November 28, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he remains a buyer of SoFi Technologies, Inc. (NASDAQ: SOFI).

Via Benzinga

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 15, 2023

From Guardant Health, Inc.

Via Business Wire

Why Is Cancer Blood Test-Focused Guardant Health Stock Trading Lower Today? ↗

November 15, 2023

Guardant Health Inc (NASDAQ: GH) shares are falling after the company announced it intends to appeal its verdict in the U.S.

Via Benzinga

Guardant Health to Appeal Federal District Court Verdict

November 15, 2023

From Guardant Health, Inc.

Via Business Wire

Cancer Test Firm Guardant Health Posts Smaller Than Expected Q3 Loss, Lifts Annual Sales Outlook ↗

November 07, 2023

Guardant Health Inc (NASDAQ: GH) reported Q3 revenue of $143 million, up 22% Y/Y, beating the consensus of $137.37 million

Via Benzinga

Guardant Health Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance

November 06, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Participate in Upcoming November Investor Conferences

November 03, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health, Flatiron Health Announce Integration of Guardant Genomic Profiling Tests Into OncoEMR® Platform

October 31, 2023

From Guardant Health, Inc.

Via Business Wire

Bull Of The Day: NeoGenomics ↗

October 24, 2023

NeoGenomics is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer.

Via Talk Markets

First results from PEGASUS trial reported at ESMO show promise for use of liquid biopsy to guide adjuvant treatment of colon cancer

October 23, 2023

From Guardant Health, Inc.

Via Business Wire

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

October 17, 2023

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END

Via FinancialNewsMedia

Guardant Health to Report Third Quarter 2023 Financial Results on November 6, 2023

October 16, 2023

From Guardant Health, Inc.

Via Business Wire

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Guardant Health, Inc. - Common Stock (NQ:GH)

All News about Guardant Health, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today